Mechanisms of Resistance in Nontyphoidal Salmonella enterica Strains Exhibiting a Nonclassical Quinolone Resistance Phenotype
- 1 September 2009
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 53 (9) , 3832-3836
- https://doi.org/10.1128/aac.00121-09
Abstract
Nontyphoidal Salmonella enterica strains with a nonclassical quinolone resistance phenotype were isolated from patients returning from Thailand or Malaysia to Finland. A total of 10 isolates of seven serovars were studied in detail, all of which had reduced susceptibility (MIC ≥ 0.125 μg/ml) to ciprofloxacin but were either susceptible or showed only low-level resistance (MIC ≤ 32 μg/ml) to nalidixic acid. Phenotypic characterization included susceptibility testing by the agar dilution method and investigation of efflux activity. Genotypic characterization included the screening of mutations in the quinolone resistance-determining regions (QRDR) of gyrA , gyrB , parC , and parE by PCR and denaturing high-pressure liquid chromatography and the amplification of plasmid-mediated quinolone resistance (PMQR) genes qnrA , qnrB , qnrS , qnrD , aac(6 ′ )-Ib-cr , and qepA by PCR. PMQR was confirmed by plasmid analysis, Southern hybridization, and plasmid transfer. No mutations in the QRDRs of gyrA , gyrB , parC , or parE were detected with the exception of a Thr57-Ser substitution within ParC seen in all but the S. enterica serovar Typhimurium strains. The qnrA and qnrS genes were the only PMQR determinants detected. Plasmids carrying qnr alleles were transferable in vitro, and the resistance phenotype was reproducible in Escherichia coli DH5α transformants. These data demonstrate the emergence of a highly mobile qnr genotype that, in the absence of mutation within topoisomerase genes, confers the nontypical quinolone resistance phenotype in S. enterica isolates. The qnr resistance mechanism enables bacteria to survive elevated quinolone concentrations, and therefore, strains carrying qnr alleles may be able to expand during fluoroquinolone treatment. This is of concern since nonclassical quinolone resistance is plasmid mediated and therefore mobilizable.Keywords
This publication has 35 references indexed in Scilit:
- qnrD , a Novel Gene Conferring Transferable Quinolone Resistance in Salmonella enterica Serovar Kentucky and Bovismorbificans Strains of Human OriginAntimicrobial Agents and Chemotherapy, 2009
- Plasmid-Mediated qepA Gene among Escherichia coli Clinical Isolates from JapanAntimicrobial Agents and Chemotherapy, 2008
- Plasmid-mediated Quinolone Resistance inSalmonella enterica, United KingdomEmerging Infectious Diseases, 2008
- New Plasmid-Mediated Fluoroquinolone Efflux Pump, QepA, Found in an Escherichia coli Clinical IsolateAntimicrobial Agents and Chemotherapy, 2007
- Changes in qnr Prevalence and Fluoroquinolone Resistance in Clinical Isolates of Klebsiella pneumoniae and Enterobacter spp. Collected from 1990 to 2005Antimicrobial Agents and Chemotherapy, 2007
- Increase in Nalidixic Acid Resistance among Non-Typhi Salmonella enterica Isolates in the United States from 1996 to 2003Antimicrobial Agents and Chemotherapy, 2007
- Prevalence in the United States of aac(6 ′ ) - Ib - cr Encoding a Ciprofloxacin-Modifying EnzymeAntimicrobial Agents and Chemotherapy, 2006
- Ciprofloxacin-resistantSalmonellaKentucky in TravelersEmerging Infectious Diseases, 2006
- qnr Prevalence in Ceftazidime-Resistant Enterobacteriaceae Isolates from the United StatesAntimicrobial Agents and Chemotherapy, 2006
- In Vivo Selection of Fluoroquinolone-Resistant Escherichia coli Isolates Expressing Plasmid-Mediated Quinolone Resistance and Expanded-Spectrum β-LactamaseAntimicrobial Agents and Chemotherapy, 2006